Gene Expression Regulation, Neoplastic

"Gene Expression Regulation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue.

Descriptor ID	D015972
MeSH Number(s)	G05.308.370
Concept/Terms	Gene Expression Regulation, Neoplastic Gene Expression Regulation, Neoplastic Regulation of Gene Expression, Neoplastic Regulation, Gene Expression, Neoplastic Neoplastic Gene Expression Regulation

Below are MeSH descriptors whose meaning is more general than "Gene Expression Regulation, Neoplastic".

Biological Sciences [G]
Genetic Phenomena [G05]
Gene Expression Regulation [G05.308]
Gene Expression Regulation, Neoplastic [G05.308.370]

Below are MeSH descriptors whose meaning is more specific than "Gene Expression Regulation, Neoplastic".

Gene Expression Regulation, Neoplastic
Gene Expression Regulation, Leukemic

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Gene Expression Regulation, Neoplastic" by people in this website by year, and whether "Gene Expression Regulation, Neoplastic" was a major or minor topic of these publications.

Bar chart showing 581 publications over 29 distinct years, with a maximum of 46 publications in 2014

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1992	1	0	1
1993	0	1	1
1995	1	0	1
1996	0	1	1
1997	0	2	2
1998	2	1	3
1999	3	1	4
2000	0	2	2
2001	2	2	4
2002	2	1	3
2003	4	8	12
2004	6	7	13
2005	8	14	22
2006	10	8	18
2007	11	13	24
2008	14	10	24
2009	12	13	25
2010	14	20	34
2011	14	14	28
2012	17	19	36
2013	16	28	44
2014	13	33	46
2015	16	21	37
2016	12	25	37
2017	7	26	33
2018	11	17	28
2019	12	24	36
2020	14	27	41
2021	4	17	21

Below are the most recent publications written about "Gene Expression Regulation, Neoplastic" by people in Profiles.

Kanga KJW, Mendonca P, Soliman KFA, Ferguson DT, Darling-Reed SF. Effect of Diallyl Trisulfide on TNF-a-induced CCL2/MCP-1 Release in Genetically Different Triple-negative Breast Cancer Cells. Anticancer Res. 2021 Dec; 41(12):5919-5933.

View in: PubMed
Rodriguez RM, Menor M, Hernandez BY, Deng Y, Khadka VS. Bacterial Diversity Correlates with Overall Survival in Cancers of the Head and Neck, Liver, and Stomach. Molecules. 2021 Sep 17; 26(18).

View in: PubMed
Najar MA, Aravind A, Dagamajalu S, Sidransky D, Ashktorab H, Smoot DT, Gowda H, Prasad TSK, Modi PK, Chatterjee A. Hyperactivation of MEK/ERK pathway by Ca2+ /calmodulin-dependent protein kinase kinase 2 promotes cellular proliferation by activating cyclin-dependent kinases and minichromosome maintenance protein in gastric cancer cells. Mol Carcinog. 2021 11; 60(11):769-783.

View in: PubMed
Jusino S, Rivera-Rivera Y, Chardón-Colón C, Ruiz-Justiz AJ, Vélez-Velázquez J, Isidro A, Cruz-Robles ME, Bonilla-Claudio M, Armaiz-Pena GN, Saavedra HI. E2F3 drives the epithelial-to-mesenchymal transition, cell invasion, and metastasis in breast cancer. Exp Biol Med (Maywood). 2021 10; 246(19):2057-2071.

View in: PubMed
Yan Y, Narayan A, Cho S, Cheng Z, Liu JO, Zhu H, Wang G, Wharram B, Lisok A, Brummet M, Saeki H, Huang T, Gabrielson K, Gabrielson E, Cope L, Kanaan YM, Afsari A, Naab T, Yfantis HG, Ambs S, Pomper MG, Sukumar S, Merino VF. CRYßB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer. Oncogene. 2021 09; 40(38):5752-5763.

View in: PubMed
Turkistani S, Sugita BM, Fadda P, Marchi R, Afsari A, Naab T, Apprey V, Copeland RL, Campbell MC, Cavalli LR, Kanaan Y. A panel of miRNAs as prognostic markers for African-American patients with triple negative breast cancer. BMC Cancer. 2021 Jul 27; 21(1):861.

View in: PubMed
Gangapuram M, Mazzio EA, Redda KK, Soliman KFA. Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel. Int J Mol Sci. 2021 Jul 19; 22(14).

View in: PubMed
Chuang TD, Quintanilla D, Boos D, Khorram O. Tryptophan catabolism is dysregulated in leiomyomas. Fertil Steril. 2021 10; 116(4):1160-1171.

View in: PubMed
Mah V, Elshimali Y, Chu A, Moatamed NA, Uzzell JP, Tsui J, Schettler S, Shakeri H, Wadehra M. ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas. Sci Rep. 2021 06 07; 11(1):11949.

View in: PubMed
Borrero-García LD, Del Mar Maldonado M, Medina-Velázquez J, Troche-Torres AL, Velazquez L, Grafals-Ruiz N, Dharmawardhane S. Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer. BMC Cancer. 2021 Jun 01; 21(1):652.

View in: PubMed

People

Explore

Similar Concepts

Top Journals